ARCHIVES

Klausner Unveils New NCI Structure, Aims To Change Institute’s “Ethos”

This article is from The Cancer Letter archive.

Vol. 21 No. 32 | August 11, 1995

Download PDF Visit The Full Archive

Related Articles

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

January 23, 1976

Alan Rabson Named Acting NCI Director

October 5, 2001

NCAB Ok’s Funding First Three Years Of Diet Trial

December 7, 1990

Southern Screening Contract Now at $2 Mil. Year For Five Year

June 7, 1974

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

February 21, 2003